Neil Dahiya

Karnataka Sets Up Committee to Address Issues in Procurement of Ringer’s Lactate IV Fluid by KSMSCL

The Karnataka administration has established a panel to delve into the discrepancies in the procurement activities of the Karnataka State Medical Supplies Corporation Limited (KSMSCL). This is specifically in response to the low-quality deliveries of Ringer’s lactate IV fluid that

Karnataka Sets Up Committee to Address Issues in Procurement of Ringer’s Lactate IV Fluid by KSMSCL Read More »

Methylcobalamin’s Revolutionary Impact on Medicine: Insights from Dr. Sanjay Agrawal

A detailed analysis of methylcobalamin’s therapeutic potential sees Dr. Sanjay Agrawal, the Scientific Advisor at Alkomex GBN USA, emphasize its essential role in contemporary medical practices. Dr. Agrawal calls for increased awareness among medical practitioners regarding methylcobalamin’s advantages. “It’s indispensable

Methylcobalamin’s Revolutionary Impact on Medicine: Insights from Dr. Sanjay Agrawal Read More »

Valisure and Picket Pharmaceuticals Form Alliance for Independent Certification of Injectable Medications

Valisure, a trailblazer in technological advancements, and Picket Pharmaceuticals, a firm tackling the ongoing challenges of drug shortages and supply chain risks for crucial pharmaceuticals in the U.S., have unveiled a strategic partnership. This collaboration will integrate Valisure’s independent chemical

Valisure and Picket Pharmaceuticals Form Alliance for Independent Certification of Injectable Medications Read More »

National Conference 2024 Shines Light on Lung Cancer Strategies with IHW Council and Top Experts

The Integrated Health & Wellbeing (IHW) Council hosted the Lung Health & Oncology National Conference 2024, emphasizing the critical importance of early detection, equitable healthcare access, and innovative treatments in confronting one of India’s most challenging cancer types. India sees

National Conference 2024 Shines Light on Lung Cancer Strategies with IHW Council and Top Experts Read More »

Independent US Trial Commences for Jaguar Health’s Crofelemer in Treating Short Bowel Syndrome with Intestinal Failure

Jaguar Health’s subsidiary, Napo Pharmaceuticals, announced the launch of an independent investigator-led trial in the United States to assess crofelemer’s efficacy and safety for treating short bowel syndrome with intestinal failure (SBS-IF) in adults. This study’s details are available on

Independent US Trial Commences for Jaguar Health’s Crofelemer in Treating Short Bowel Syndrome with Intestinal Failure Read More »